That’s what this drug company is trying to do. It probably would be better to spend their resources trying to find something new, rather than repackaging old drugs (case in point: BiDil).
Related posts:
- Racist not to cover BiDil?
- BiDil smoke and mirrors
- Are generic drugs truly equivalent to brand name medications?
- Avandia: GSK strikes back
- Are generic medications as good as their brand name counterparts?
- Generics versus brand-name drugs
- Dosing amoxicillin
KevinMD.com on Facebook
Comments on this entry are closed.